Starting treatment with angiotensin converting enzyme inhibitors in heart failure: how, where, and how much?
AUTOR(ES)
Coats, A J
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1025036Documentos Relacionados
- Angiotensin converting enzyme inhibitors in heart failure: how good are they?
- Nitric oxide synthases: which, where, how, and why?
- Converting enzyme inhibitors in hypertension and heart failure.
- Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure.
- Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.